These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1312 related articles for article (PubMed ID: 16604564)
21. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins. Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190 [TBL] [Abstract][Full Text] [Related]
22. Optimal management of ductal carcinoma in situ of the breast. Sakorafas GH; Farley DR Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563 [TBL] [Abstract][Full Text] [Related]
23. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision. Renshaw AA; Derhagopian RP; Martinez P; Gould EW Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208 [TBL] [Abstract][Full Text] [Related]
24. Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome. Mazouni C; Peintinger F; Wan-Kau S; Andre F; Gonzalez-Angulo AM; Symmans WF; Meric-Bernstam F; Valero V; Hortobagyi GN; Pusztai L J Clin Oncol; 2007 Jul; 25(19):2650-5. PubMed ID: 17602071 [TBL] [Abstract][Full Text] [Related]
25. Lobular carcinoma in situ (LCIS): pathology and treatment. Gump FE J Cell Biochem Suppl; 1993; 17G():53-8. PubMed ID: 8007710 [TBL] [Abstract][Full Text] [Related]
26. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy. Jolly S; Kestin LL; Goldstein NS; Vicini FA Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988 [TBL] [Abstract][Full Text] [Related]
27. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience. Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223 [TBL] [Abstract][Full Text] [Related]
28. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Li CI; Malone KE; Daling JR Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):601-7. PubMed ID: 12101106 [TBL] [Abstract][Full Text] [Related]
29. Lobular neoplasia. Long term risk of breast cancer and relation to other factors. Bodian CA; Perzin KH; Lattes R Cancer; 1996 Sep; 78(5):1024-34. PubMed ID: 8780540 [TBL] [Abstract][Full Text] [Related]
30. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies. Renshaw AA; Gould EW Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205 [TBL] [Abstract][Full Text] [Related]
31. Lobular carcinoma in situ. Afonso N; Bouwman D Eur J Cancer Prev; 2008 Aug; 17(4):312-6. PubMed ID: 18562954 [TBL] [Abstract][Full Text] [Related]
32. Do breast columnar cell lesions with atypia need to be excised? Datrice N; Narula N; Maggard M; Butler J; Hsiang D; Baick C; Lane K Am Surg; 2007 Oct; 73(10):984-6. PubMed ID: 17983063 [TBL] [Abstract][Full Text] [Related]
33. Clinical importance of histologic grading of lobular carcinoma in situ in breast core needle biopsy specimens: current issues and controversies. Gao F; Carter G; Tseng G; Chivukula M Am J Clin Pathol; 2010 May; 133(5):767-71. PubMed ID: 20395524 [TBL] [Abstract][Full Text] [Related]
34. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters. Naidu R; Wahab NA; Yadav MM; Kutty MK Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618 [TBL] [Abstract][Full Text] [Related]
35. Lobular carcinoma of the breast in situ and infiltrating. Wheeler JE; Enterline HT Pathol Annu; 1976; 11():161-88. PubMed ID: 188001 [TBL] [Abstract][Full Text] [Related]
36. The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis. Warren JL; Weaver DL; Bocklage T; Key CR; Platz CE; Cronin KA; Ballard-Barbash R; Willey SC; Harlan LC Cancer; 2005 Nov; 104(9):1840-8. PubMed ID: 16136599 [TBL] [Abstract][Full Text] [Related]
38. TNM staging and classification (familial and nonfamilial) of breast cancer in Jordanian females. Atoum MF; Hourani HM; Shoter A; Al-Raheem SN; Al Muhrib TK Indian J Cancer; 2010; 47(2):194-8. PubMed ID: 20448386 [TBL] [Abstract][Full Text] [Related]
39. Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer. Katz A; Gage I; Evans S; Shaffer M; Fleury T; Smith FP; Flax R; Drogula C; Petrucci P; Magnant C Am J Surg; 2006 Jun; 191(6):761-6. PubMed ID: 16720145 [TBL] [Abstract][Full Text] [Related]
40. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary? Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]